Filter
1148
Filtered Results: 1148
Text search:
serology
Featured
Recommendations
147
New Publications
312
Language
Document type
No document type
581
Guidelines
291
Studies & Reports
133
Manuals
53
Fact sheets
32
Strategic & Response Plan
31
Situation Updates
10
Training Material
8
Infographics
7
Brochures
1
Resource Platforms
1
Countries / Regions
India
55
Global
41
Germany
36
Latin America and the Carribbean
29
Paraguay
28
Nigeria
26
South Africa
26
Western and Central Europe
22
Argentina
21
Colombia
19
Africa
19
Ethiopia
19
Philippines
18
Bangladesh
17
Kenya
16
Tanzania
16
Venezuela
15
Nepal
12
Sierra Leone
12
Zambia
12
Mozambique
11
West and Central Africa
11
Rwanda
10
Malawi
10
Bolivia
10
Uganda
10
Brazil
10
Indonesia
10
East and Southern Africa
9
Ghana
8
Congo, Democratic Republic of
8
Eastern Europe
8
Russia
8
Peru
7
Liberia
7
Lesotho
6
Middle East and North Africa
6
Ukraine
5
Senegal
5
Asia
5
Namibia
5
Angola
5
Myanmar / Burma
5
Pakistan
5
Syria
4
Burkina Faso
4
USA
4
South–East Asia Region
4
Spain
4
Ecuador
4
China
3
Cameroon
3
Afghanistan
3
Zimbabwe
3
Haiti
3
Cambodia
3
Eastern Europe and Central Asia
3
France
3
Vietnam
3
Central African Republic
3
South Sudan
3
North Macedonia
2
Mexico
2
El Salvador
2
Turkey
2
Benin
2
Iran
2
Albania
2
Guinea
2
Jordan
2
Saudi Arabia
2
Uruguay
2
Portugal
2
Côte d’Ivoire / Ivory Coast
2
Lebanon
2
Sudan
2
Chad
2
Botswana
2
Iraq
2
Eswatini/ Swaziland
2
Tajikistan
1
Australia
1
Togo
1
Chile
1
Laos
1
Morocco
1
Qatar
1
Italy
1
Guinea-Bissau
1
Western Pacific Region
1
North America
1
Tunisia
1
United Kingdom
1
Southern Africa
1
Papua New Guinea
1
Sri Lanka
1
Djibouti
1
Egypt
1
Yemen
1
Greece
1
Palestine
1
Georgia
1
Honduras
1
Mali
1
Libya
1
Bhutan
1
Somalia
1
Madagascar
1
Authors & Publishers
Publication Years
Category
Countries
461
Clinical Guidelines
182
Pharmacy & Technologies
47
Public Health
36
Women & Child Health
22
Key Resources
18
Capacity Building
5
Toolboxes
COVID-19
163
HIV
122
NTDs
119
Rapid Response
97
TB
63
Zika
57
Refugee
26
Ebola
26
AMR
18
Mental Health
16
Pharmacy
15
Planetary Health
14
Caregiver
11
Polio
9
Cholera
6
Natural Hazards
5
NCDs
4
Conflict
3
Global Health Education
3
Disability
1
Trypanosoma cruzi is the etiological agent of Chagas disease (CD), considered one of the most important parasitic infections in Latin America. Between 25 and 90 million humans are at infection risk via at least one of multiple infection mechanisms. Under natural conditions, the principal transmissio...
This report provides a review and analysis of the research landscape for three diseases – Chagas disease, human African trypanosomiasis and leishmaniasis – that disproportionately afflict poor and remote populations with limited access to health services. It represents the work of the disease re...
Theodor Bilharz, a German professor of anatomy and chief of surgery at the Kasr El Ani Hospital of Cairo from 1850, first identified an infective organism, Distomum hematobium in 1851, which was renamed Schistosoma haematobium in 1858. It arose from a cestode worm, Hymenoleptis nana, lying in the sm...
This document focuses on the management of patients affected by gambiense HAT and
constitutes an update to the WHO therapeutic guidance issued in 2013. The main changes in recommendations concern the criteria and methods for deciding the treatment among the new set of therapeutic options and the pa...
In support of the London Declaration goals, PATH aims to catalyze engagement of the diagnostics industry and product development efforts. As part of this work, PATH conducted a diagnostic landscape analysis to identify gaps and evaluated current and nascent HAT diagnostics that may provide solutions...
Since 2000, concerted efforts by national programmes, supported by public–private partnerships, nongovernmental organizations, donors and academia under the auspices and coordination of the World Health Organization (WHO), have produced important achievements in the control of human African trypan...
Background: The World Health Organization (WHO) published a clinical case definition of post COVID-19
condition, by a Delphi consensus, on 6 October 2021. That process concluded that a separate definition
may be applicable for children. It is important to understand the frequency, characteristics ...
An interregional meeting on leishmaniasis among neighbouring endemic
countries in the Eastern Mediterranean, African and European regions was organized by the World Health Organization (WHO) Regional Office for the Eastern
Mediterranean in Amman, Jordan, from 23 to 25 September 2018. The meeting w...
This analysis focused on the chronic form of HAT caused by T. b. gambiense, as it contributes to the majority of disease burden. Information from the literature review,
product development landscape, and stakeholder interviews was compiled to:
- Identify use cases and understand current diagnosti...
The objectives of the meeting were:
1. To step up the commitment of national authorities and technical and financial partners toWHO’s elimination objective for g-HAT.
2. To share achievements, challenges and views on the elimination goal among countries and implementing partners.
3. To assess t...
The major neglected tropical diseases, Taenia solium taeniosis/cysticercosis and schistosomiasis caused by Schistosoma mansoni or S. haematobium are presumed to be widely distributed in Africa. Taenia solium taeniosis/ cysticercosis has been reported as an emerging disease in different regions of Af...
As of 12 December 2022, over 645 million people worldwide have been diagnosed with COVID-19, with over 6.6 million deaths (4).
The Omicron variant, which emerged in late November 2021, and its subvariants, are now the dominant circulating viruses, contributing to the ongoing surge in several countr...
Rabies is a fatal viral zoonosis and serious public health problem.1 All mammals are believed to be susceptible to the disease, and for the purposes of this document, use of the term animal refers to mammals. The disease is an acute, progressive encephalitis caused by viruses in the genus Lyssavirus...
BMJ Open 2021;11:e042279. doi:10.1136/bmjopen-2020-042279. Neglected tropical diseases tend to cluster in the same poor populations, and to make progress with their control, they will have to be dealt with in an integrated manner. Peptide microarrays may be a solution to tese problems, where diagnos...
В дорожной карте по борьбе с забытыми тропическими болезнями на 2021–2030 гг. («дорожная карта») определены глобальные цели и основные этапы в отношении борьбы с 20 бол...
Cystic echinococcosis (CE) is a well-known neglected parasitic disease. However, evidence supporting the four current treatment modalities is inadequate, and treatment options remain controversial. The aim of this work is to analyse the available data to answer clinical questions regarding medical t...
The waves of yellow fever transmission in the Region of the Americas in 2016–2018 involved the largest number of human and epizootic cases to be reported in several decades. Yellow fever is a serious viral hemorrhagic disease that poses a challenge for health professionals. It requires early recog...
The WHO COVID-19 Clinical management: living guidance contains the most up-to-date recommendations for the clinical management of people with COVID-19. Providing guidance that is comprehensive and holistic for the optimal care of COVID-19 patients throughout their entire illness is important.
Building on the 2021 Interim guidance, this second version and update, incorporates the lessons and feedback from the hepatitis pilots that successfully demonstrated the feasibility of measuring hepatitis B and C impact targets to demonstrate elimination, whilst highlighting challenges caused by hig...
Hepatitis B (HBV) infection is a major public health problem and cause of chronic liver disease.
The 2024 HBV guidelines provide updated evidence-informed recommendations on key priority topics. These include expanded and simplified treatment criteria for adults but now also for adolescents; expa...
